143 related articles for article (PubMed ID: 1903340)
41. Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro.
Gerber AU; Wiprächtiger P; Stettler-Spichiger U; Lebek G
J Infect Dis; 1982 Apr; 145(4):554-60. PubMed ID: 6802906
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Blaser J
J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863
[TBL] [Abstract][Full Text] [Related]
43. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa.
Bayer AS; Speert DP; Park S; Tu J; Witt M; Nast CC; Norman DC
Infect Immun; 1991 Jan; 59(1):302-8. PubMed ID: 1898898
[TBL] [Abstract][Full Text] [Related]
44. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.
Zinner SH; Provonchee RB; Elias KS; Peter G
Antimicrob Agents Chemother; 1976 Apr; 9(4):661-4. PubMed ID: 817663
[TBL] [Abstract][Full Text] [Related]
45. Cefotaxime aminoglycoside interactions.
Pierce MA; Elliott AM; Cobbs CG
Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
[TBL] [Abstract][Full Text] [Related]
46. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa.
Park MK; Muhvich KH; Myers RA; Marzella L
Antimicrob Agents Chemother; 1991 Apr; 35(4):691-5. PubMed ID: 1906262
[TBL] [Abstract][Full Text] [Related]
47. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.
Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA
Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751
[TBL] [Abstract][Full Text] [Related]
48. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
Larson TA; Peterson LR; Gerding DN
J Clin Microbiol; 1985 Nov; 22(5):819-21. PubMed ID: 3932459
[TBL] [Abstract][Full Text] [Related]
49. An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides.
Woolfrey BF; Fox JM; Quall CO
Am J Clin Pathol; 1981 Apr; 75(4):559-64. PubMed ID: 6784571
[TBL] [Abstract][Full Text] [Related]
50. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.
Daikos GL; Jackson GG; Lolans VT; Livermore DM
J Infect Dis; 1990 Aug; 162(2):414-20. PubMed ID: 2115555
[TBL] [Abstract][Full Text] [Related]
51. Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa.
Muhvich KH; Park MK; Myers RA; Marzella L
Antimicrob Agents Chemother; 1989 Sep; 33(9):1526-30. PubMed ID: 2510593
[TBL] [Abstract][Full Text] [Related]
52. Different patterns of bacterial DNA synthesis during postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
[TBL] [Abstract][Full Text] [Related]
53. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
Bassler M; Blaschke H; Just M; Daschner FD
Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
[TBL] [Abstract][Full Text] [Related]
54. The effect of sublethal concentrations of aminoglycosides on adherence of Pseudomonas aeruginosa to hamster tracheal epithelium.
Geers TA; Baker NR
J Antimicrob Chemother; 1987 May; 19(5):561-8. PubMed ID: 3112091
[TBL] [Abstract][Full Text] [Related]
55. In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.
Shalit I; Welch DF; San Joaquin VH; Marks MI
Antimicrob Agents Chemother; 1985 Jun; 27(6):908-11. PubMed ID: 3927837
[TBL] [Abstract][Full Text] [Related]
56. Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.
Jorgensen JH; Lee JC; Jones PM
Antimicrob Agents Chemother; 1977 Mar; 11(3):415-9. PubMed ID: 404961
[TBL] [Abstract][Full Text] [Related]
57. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
Fantin B; Ebert S; Leggett J; Vogelman B; Craig WA
J Antimicrob Chemother; 1991 Jun; 27(6):829-36. PubMed ID: 1938689
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.
Zhanel GG; Craig WA
Clin Pharmacokinet; 1994 Nov; 27(5):377-92. PubMed ID: 7851055
[TBL] [Abstract][Full Text] [Related]
59. Relative antagonism in vitro of calcium in serum to the bactericidal activities of gentamicin and tobramycin on Pseudomonas aeruginosa.
Davis SD; Iannetta A
Chemotherapy; 1973 Oct; 19(4):243-53. PubMed ID: 4204086
[No Abstract] [Full Text] [Related]
60. Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments.
Woolfrey BF; Fox JM; Lally RT; Quall CO
J Clin Microbiol; 1982 Oct; 16(4):663-7. PubMed ID: 6818244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
